These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 7260485

  • 1. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.
    Cusack NJ, Hourani SM.
    Br J Pharmacol; 1981 Mar; 72(3):443-7. PubMed ID: 7260485
    [Abstract] [Full Text] [Related]

  • 2. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
    Cooper JA, Hill SJ, Alexander SP, Rubin PC, Horn EH.
    Br J Clin Pharmacol; 1995 Jul; 40(1):43-50. PubMed ID: 8527267
    [Abstract] [Full Text] [Related]

  • 3. Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.
    Ukena D, Böhme E, Schwabe U.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):36-42. PubMed ID: 6092968
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet aggregation by adenosine receptor agonists.
    Cristalli G, Vittori S, Thompson RD, Padgett WL, Shi D, Daly JW, Olsson RA.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):644-50. PubMed ID: 7969516
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 6. Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues.
    Hourani SM, Boon K, Fooks HM, Prentice DJ.
    Br J Pharmacol; 2001 Jul 15; 133(6):833-40. PubMed ID: 11454656
    [Abstract] [Full Text] [Related]

  • 7. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.
    Hüttemann E, Ukena D, Lenschow V, Schwabe U.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar 15; 325(3):226-33. PubMed ID: 6328333
    [Abstract] [Full Text] [Related]

  • 8. Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events.
    Clark JC, Kavanagh DM, Watson S, Pike JA, Andrews RK, Gardiner EE, Poulter NS, Hill SJ, Watson SP.
    Thromb Haemost; 2019 Jul 15; 119(7):1124-1137. PubMed ID: 31129912
    [Abstract] [Full Text] [Related]

  • 9. Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets.
    Edwards RJ, MacDermot J, Wilkins AJ.
    Br J Pharmacol; 1987 Mar 15; 90(3):501-10. PubMed ID: 2436701
    [Abstract] [Full Text] [Related]

  • 10. In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.
    Sandoli D, Chiu PJ, Chintala M, Dionisotti S, Ongini E.
    Eur J Pharmacol; 1994 Jun 23; 259(1):43-9. PubMed ID: 7957592
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
    Monopoli A, Conti A, Zocchi C, Casati C, Volpini R, Cristalli G, Ongini E.
    Arzneimittelforschung; 1994 Dec 23; 44(12):1296-304. PubMed ID: 7848347
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of cyclic adenosine monophosphate accumulation causes breakdown of the blood-retinal barrier.
    Sen HA, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 1991 Jun 23; 32(7):2006-10. PubMed ID: 1647374
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery.
    Sabouni MH, Cushing DJ, Makujina SR, Mustafa SJ.
    J Pharmacol Exp Ther; 1991 Nov 23; 259(2):508-12. PubMed ID: 1658301
    [Abstract] [Full Text] [Related]

  • 14. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
    Cusack NJ, Hourani SM.
    Br J Pharmacol; 1981 Jun 23; 73(2):409-12. PubMed ID: 7236993
    [Abstract] [Full Text] [Related]

  • 15. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
    Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I.
    Mol Pharmacol; 1990 Jun 23; 37(6):870-5. PubMed ID: 2359405
    [Abstract] [Full Text] [Related]

  • 16. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
    Söderbäck U, Sollevi A.
    Thromb Res; 1991 Nov 01; 64(3):355-62. PubMed ID: 1666697
    [Abstract] [Full Text] [Related]

  • 17. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 01; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 18. Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
    Prentice DJ, Payne SL, Hourani SM.
    Br J Pharmacol; 1997 Dec 01; 122(7):1509-15. PubMed ID: 9421303
    [Abstract] [Full Text] [Related]

  • 19. Adenotin and adenotin-like proteins coexist with adenosine receptors in mammalian tissues.
    Work C, Zolnierowicz S, Hutchinson KA, Prasad M, Fox IH.
    J Lab Clin Med; 1991 Mar 01; 117(3):250-8. PubMed ID: 1848270
    [Abstract] [Full Text] [Related]

  • 20. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
    Cristalli G, Volpini R, Vittori S, Camaioni E, Monopoli A, Conti A, Dionisotti S, Zocchi C, Ongini E.
    J Med Chem; 1994 May 27; 37(11):1720-6. PubMed ID: 8201607
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.